3 completed, 2 withdrawn, 1 unknown. 4 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 2, Unknown 1, Withdrawn 1 |
| Phase 1 | 1 | Completed 1 |
Follow ibandronate sodium: new trials by email Literature Review of ibandronate sodium trials Research Report on ibandronate sodium
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| S0307A, Long-Term Bone Quality in Women With Breast Cancer Enrolled on Clinical Trial SWOG-S0307 clodronate disodium, demeclocycline hydrochloride, ibandronate sodium - Breast Cancer | Withdrawn | SWOG Cancer Research Network | 2008-10-01 | 2013-04-10 | ||
| Bioequivalence Study of Ibandronate Sodium Tablets 150 mg Under Fasting Condition Ibandronate sodium - Healthy | Phase 1 | Completed | Dr. Reddy's Laboratories Limited | 100 | 2008-09-01 | 2012-06-28 |
| S0308 Zoledronate or Ibandronate in Preventing Bone Problems in Women With Stage IV Breast Cancer That Has Spread to the Bone ibandronate, zoledronate, quality-of-life assessment - Breast Cancer, Hypercalcemia of Malignancy | Phase 3 | Withdrawn | SWOG Cancer Research Network | 2006-05-01 | 2013-11-13 | |
| Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast Cancer ibandronate sodium, zoledronic acid, Zolendronic Acid - Breast Cancer, Hypercalcemia of Malignancy | Phase 3 | Unknown | Wales Cancer Trials Unit | 1404 | 2006-01-01 | 2013-03-13 |
| S0307 Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer. clodronate disodium, ibandronate sodium, zoledronic acid - Breast Cancer | Phase 3 | Completed | SWOG Cancer Research Network | 6097 | 2005-07-01 | 2021-07-02 |
| Single-Dose Local Radiation Therapy Compared With Ibandronate in Treating Patients With Localized Metastatic Bone Pain ibandronate sodium - Metastatic Cancer, Pain | Phase 3 | Completed | Cancer Research UK | 580 | 2003-04-01 | 2013-06-26 |
Breast Neoplasms (4) · Neoplasm Metastasis (3) · Humoral Hypercalcemia Of Malignancy (2) · Pain (2) · Breast Neoplasms, Male (1) · Prostatic Neoplasms (1)
SWOG Cancer Research Network (3) · Cancer Research UK (1) · Dr. Reddy's Laboratories Limited (1) · Wales Cancer Trials Unit (1)
United Kingdom (2) · India (1) · United States (1)
Dawn Hershman, MD (2) · Alexander H Paterson, MD, FRCP (1) · Carla I. Falkson, MD (1) · Dr. Simran Sethi, MBBS (1) · Elizabeth C. Dees, MD (1) · Heather Purnell (1) · James N. Ingle, MD (1) · Julie R. Gralow, MD (1) · Katherine Monson (1) · Kathy S. Albain, MD (1) · Mark J. Clemons, MD (1) · Peter J. Barrett Lee, MD (1) · Robert B. Livingston, MD (1) · Saul E. Rivkin, MD (1)
PMID 24332514, PMID 28274254, PMID 32929540, PMID 38979716
U10CA032102 (1), U10CA037429 (1)